Header cover image

Hong Kong (HSI) Healthcare Services Industry Analysis

UpdatedFeb 21, 2024
DataAggregated Company Financials
Companies57
  • 7D4.2%
  • 3M-11.3%
  • 1Y-22.9%
  • YTD-4.5%

In the last week, the Healthcare Services industry is up 4.2%, with Sinopharm Group up 5.1%. During this same period, the IVD Medical Holding underperformed, falling 13%. In contrast, the industry has lost 23% in the last 12 months. Earnings are forecast to grow by 21% annually.

Industry Valuation and Performance

Has the Hong Kong Healthcare Services Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 21 Feb 2024HK$243.6bHK$814.8bHK$12.0b14.3x20.2x0.3x
Fri, 19 Jan 2024HK$234.6bHK$815.5bHK$12.0b15.1x19.5x0.3x
Sun, 17 Dec 2023HK$243.5bHK$821.5bHK$12.5b15x19.5x0.3x
Tue, 14 Nov 2023HK$251.0bHK$803.3bHK$12.2b13.4x20.5x0.3x
Thu, 12 Oct 2023HK$289.3bHK$802.4bHK$12.3b13.7x23.5x0.4x
Sat, 09 Sep 2023HK$275.6bHK$800.7bHK$12.7b12.8x21.8x0.3x
Mon, 07 Aug 2023HK$306.4bHK$786.1bHK$11.5b11.5x26.6x0.4x
Wed, 05 Jul 2023HK$310.9bHK$788.4bHK$1.5b12x211.1x0.4x
Fri, 02 Jun 2023HK$309.2bHK$776.5bHK$827.5m11.4x373.7x0.4x
Sun, 30 Apr 2023HK$336.9bHK$799.3bHK$1.3b11.5x261.9x0.4x
Tue, 28 Mar 2023HK$323.6bHK$790.6bHK$2.3b15.5x138.7x0.4x
Thu, 23 Feb 2023HK$312.2bHK$782.8bHK$3.3b16.3x95.6x0.4x
Sat, 21 Jan 2023HK$310.7bHK$793.9bHK$3.5b16.2x89.1x0.4x
Mon, 19 Dec 2022HK$295.2bHK$768.4bHK$3.0b14.5x100x0.4x
Wed, 16 Nov 2022HK$264.8bHK$762.5bHK$2.3b14.2x117x0.3x
Fri, 14 Oct 2022HK$191.3bHK$662.5b-HK$2,191,284,098.0013x-87.3x0.3x
Sun, 11 Sep 2022HK$212.4bHK$684.6b-HK$2,361,071,723.0016.6x-90x0.3x
Tue, 09 Aug 2022HK$227.9bHK$690.7b-HK$6,931,632,339.0017.6x-32.9x0.3x
Thu, 07 Jul 2022HK$245.6bHK$694.3b-HK$6,994,368,526.0017.6x-35.1x0.4x
Sat, 04 Jun 2022HK$209.8bHK$697.8b-HK$6,168,946,059.0016.8x-34x0.3x
Mon, 02 May 2022HK$200.5bHK$692.3b-HK$6,927,615,769.0017.3x-28.9x0.3x
Wed, 30 Mar 2022HK$206.5bHK$724.6b-HK$4,774,655,154.0017.5x-43.3x0.3x
Fri, 25 Feb 2022HK$251.6bHK$721.8b-HK$5,274,794,309.0017.3x-47.7x0.3x
Sun, 23 Jan 2022HK$262.3bHK$717.0b-HK$5,292,510,175.0018.5x-49.6x0.4x
Tue, 21 Dec 2021HK$234.3bHK$711.8b-HK$5,426,268,197.0017.4x-43.2x0.3x
Thu, 18 Nov 2021HK$295.8bHK$708.5b-HK$5,401,819,782.0017.8x-54.8x0.4x
Sat, 16 Oct 2021HK$324.7bHK$693.0b-HK$5,366,863,952.0016.6x-60.5x0.5x
Mon, 13 Sep 2021HK$343.3bHK$689.6b-HK$5,408,746,530.0217.1x-63.5x0.5x
Wed, 11 Aug 2021HK$478.1bHK$689.6b-HK$5,408,746,530.0216.4x-88.4x0.7x
Sun, 06 Jun 2021HK$743.1bHK$647.2b-HK$3,726,135,594.8920.3x-199.4x1.1x
Wed, 10 Mar 2021HK$321.1bHK$596.1bHK$8.0b23.2x40x0.5x
Price to Earnings Ratio

40x


Total Market Cap: HK$321.1bTotal Earnings: HK$8.0bTotal Revenue: HK$596.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Hong Kong Healthcare Services Industry Price to Earnings3Y Average -84.8x202220232024
Current Industry PE
  • Investors are pessimistic on the Hong Kong Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 20.2x which is higher than its 3-year average PE of -84.8x.
  • The industry is trading close to its 3-year average PS ratio of 0.48x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 14% per year over the last three years.
  • Revenues for these companies have grown 11% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Hong Kong Healthcare industry?

HK Market3.54%
Healthcare5.38%
Healthcare Services4.15%
Healthcare Facilities6.43%
Healthcare Services6.01%
Healthcare Distributors2.64%
Managed Healthcare-4.55%
Industry PE
  • Investors are most optimistic about the Healthcare Facilities industry which is trading above its 3-year average PE ratio of 3.0x.
    • Analysts are expecting annual earnings growth of 39.5%, which is higher than its past year's earnings decline of 14.8% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Facilities industry, expecting annual earnings growth of 40% over the next 5 years.
  • This is better than its past earnings decline of 15% per year.
  • In contrast, the Healthcare Distributors industry is expected to see its earnings grow by 11% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
1099 Sinopharm GroupHK$21.704.8%
+HK$3.1b
-0.7%PE7.1x
6078 Hygeia Healthcare HoldingsHK$29.7512.9%
+HK$2.1b
-45.5%PE29.4x
2273 Gushengtang HoldingsHK$44.2016.2%
+HK$1.5b
-19.2%PE44.7x
874 Guangzhou Baiyunshan Pharmaceutical HoldingsHK$20.504.4%
+HK$1.4b
-10.9%PE7.1x
9885 YSBHK$7.9922.2%
+HK$928.7m
n/aPS0.3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

1951

HK$2.41

Jinxin Fertility Group

7D

15.3%

1Y

-61.7%

2273

HK$44.20

Gushengtang Holdings

7D

16.2%

1Y

-19.2%

1931

HK$1.89

IVD Medical Holding

7D

-4.5%

1Y

24.3%

3390

HK$4.63

Tycoon Group Holdings

7D

-3.3%

1Y

12.1%

1515

HK$4.52

China Resources Medical Holdings

7D

14.4%

1Y

-31.5%

1846

HK$4.89

EuroEyes International Eye Clinic

7D

-3.6%

1Y

-13.1%

6078

HK$29.75

Hygeia Healthcare Holdings

7D

12.9%

1Y

-45.5%

2453

HK$15.68

Concord Healthcare Group

7D

8.1%

1Y

n/a

9955

HK$5.54

ClouDr Group

7D

-1.9%

1Y

-12.1%

9885

HK$7.99

YSB

7D

22.2%

1Y

n/a

9960

HK$1.46

Kindstar Globalgene Technology

7D

-2.7%

1Y

-34.2%